logo-loader
viewNemaura Medical Inc

Nemaura launches shipments of its SugarBEAT glucose monitor to the UK

The SugarBEAT works for patients with diabetes or prediabetes by testing their blood glucose levels using a sensor on the skin, rather than using a needle

SugarBEAT continuous glucose monitor
The wave of shipments is Nemaura’s first foray into the European market after receiving its CE mark in May

Nemaura Medical Inc (NASDAQ:NMRD) has launched shipments of its SugarBEAT continuous glucose monitors to patients in the United Kingdom, the company announced Wednesday.

The wave of shipments is the company’s first foray into the European market after receiving its CE mark, an EU seal of approval, in May. 

The SugarBEAT monitor works for patients with diabetes or prediabetes by testing their blood glucose levels using a sensor on the skin, rather than using a needle to puncture the skin and draw a blood sample.

READ: Nemaura receives $8 million credit facility from major shareholders

“We are very pleased to have commenced the first phase of our commercial launch,” CEO Faz Chowdhury said in a statement. “This represents a major achievement for the company as we transition from product development to a full-fledged commercial organization.”

The company already has an eager British clientele. Nemaura reported that its UK licensee has registered more than 17,000 expressions of interest from potential users on its website. 

The Loughborough, England-based company plans to present data from its first European users at the European Association for the Study of Diabetes conference in Barcelona on September 19.

Contact Andrew Kessel at [email protected] 

Follow him on Twitter @andrew_kessel

Quick facts: Nemaura Medical Inc

Price: 4.98 USD

NASDAQ:NMRD
Market: NASDAQ
Market Cap: $103.83 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Nemaura Medical Inc named herein, including the promotion by the Company of Nemaura Medical Inc in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: SDX Energy hits stable production at South Disouq

Headlines from the Proactive UK newsroom. SDX Energy (LON:SDX) has achieved stable production at its South Disouq concession in Egypt three months earlier than initially expected. Gas has been flowing since 7 November at a fixed price.  Eco Atlantic (LON:ECO) and its partners on the...

1 day, 10 hours ago

2 min read